This activity is supported by an educational grant from Mylan Specialty L.P., a Viatris Company, and an educational grant from Theravance.
Program Description
Each year, experts review evidence-based updates in the prevention, diagnosis, and management of chronic obstructive pulmonary disease (COPD) and update the Global Initiative for Chronic Obstructive Lung Disease (GOLD) guidelines to reflect significant changes from the scientific literature. This webinar outlines these noteworthy updates to the most recent GOLD COPD report and the impact of new information for pharmacists and pharmacy technicians. Pharmacists and pharmacy technicians will be able to effectively interpret the new guideline updates and implement them into their practice to improve the care for patients with COPD.
Target audience: Health-system and retail pharmacists
Type of activity: Application for pharmacists
Release date: February 8, 2024
Expiration date: February 8, 2025
Time to complete activity: 1.0 hour
Learner level: Foundational, Intermediate
Fee: Free
Educational Objectives
At the completion of this activity, participants will be able to:
Educational objectives (Pharmacists):
- Examine the most recent changes and updates to the GOLD guidelines for treating and managing chronic obstructive pulmonary disease
- Employ the current GOLD guidelines to make evidence-based clinical recommendations to individualize patient therapy and ensure proper inhaler selection and technique to improve adherence and clinical outcomes
Rupal Mansukhani, PharmD
Clinical Professor
Ernest Mario School of Pharmacy
Rutgers University
Piscataway, New Jersey
Clinical Pharmacist
Morristown Medical Center
Morristown, New Jersey
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. This activity is approved for 1.0 contact hour (0.10 CEU) under the ACPE universal activity numbers 0290-0000-24-006-H01-P and 0290-0000-24-007-H01-T. The activity is available for CE credit through February 8, 2025.
Instructions for Completing the Activity and Receiving CPE Credit
To receive CPE credit, participants must complete the pretest, review the activity in its entirety, complete the posttest, and complete the online activity evaluation. After successful completion of the online activity evaluation, you can submit your credit to CPE Monitor. You may view your credit within 48 hours at www.mycpemonitor.net. All participants must request credit before the activity expiration date. CE credit will not be issued after this date.
Disclosures
The following contributors have no relevant financial relationships with commercial interests to disclose:
Faculty
Rupal Mansukhani, PharmD
Pharmacy Times Continuing Education™ Planning Staff—Jim Palatine, RPh, MBA; Maryjo Dixon, RPh, MBA; Rose Namissa-Buszka, PharmD, BCPS, CHCP; Angelica Archibald; Susan Pordon; Brianna Winters; Chloe Taccetta; and Rebecca Green have no relevant financial relationships with commercial interests to disclose.
An anonymous peer reviewer was used as part of content validation and conflict resolution. The peer reviewer has no relevant financial relationships with commercial interests to disclose.
Educational Disclaimer
CPE activities are offered solely for educational purposes and do not constitute any form of professional advice or referral. Discussions concerning drugs, dosages, and procedures may reflect the clinical experience of the author(s) or they may be derived from the professional literature or other sources and may suggest uses that are investigational in nature and not approved labeling or indications. Participants are encouraged to refer to primary references or full prescribing information resources.
For questions about this internet CPE activity, please contact:
[email protected]
Privacy Policy and Terms of Use Information:
www.pharmacytimes.org/terms
